{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:50:22Z","timestamp":1761540622302},"reference-count":21,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T00:00:00Z","timestamp":1110240000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The molecular pathogenesis of type 1 von Willebrand disease (VWD) is uncertain in most patients. We examined 30 type 1 VWD families in the UK Haemophilia Centre Doctors\u2019 Organization study. Heterozygosity for Y\/C1584 was present in eight of 30 (27%) families and 19 of 76 (25%) individuals with type 1 VWD recruited into the study. Eighteen (95%) of these 19 individuals were blood group O. C1584 did not co\u2010segregate with VWD in four families, and co\u2010segregated in one family; the results were equivocal in three families. In all families increased susceptibility of von Willebrand factor (VWF) to a disintegrin and metalloprotease with thrombospondin motifs (ADAMTS) 13 proteolysis co\u2010segregated with C1584 in affected and unaffected individuals. These data show that C1584, associated with blood group O, is prevalent among patients with type 1 VWD but not necessarily causative of disease and should not be used in isolation to diagnose VWD. Increased susceptibility of C1584 VWF to ADAMTS13 proteolysis may be physiologically significant and increase an individual's risk of bleeding and presenting with VWD.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05375.x","type":"journal-article","created":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T13:03:16Z","timestamp":1110286996000},"page":"830-836","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co\u2010segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype"],"prefix":"10.1111","volume":"128","author":[{"given":"Derrick J.","family":"Bowen","sequence":"first","affiliation":[]},{"given":"Peter W.","family":"Collins","sequence":"additional","affiliation":[]},{"given":"Will","family":"Lester","sequence":"additional","affiliation":[]},{"given":"Anthony M.","family":"Cumming","sequence":"additional","affiliation":[]},{"given":"Steven","family":"Keeney","sequence":"additional","affiliation":[]},{"given":"Pamela","family":"Grundy","sequence":"additional","affiliation":[]},{"given":"Saad M.","family":"Enayat","sequence":"additional","affiliation":[]},{"given":"Paula H. B.","family":"Bolton\u2010Maggs","sequence":"additional","affiliation":[]},{"given":"David M.","family":"Keeling","sequence":"additional","affiliation":[]},{"given":"Kate","family":"Khair","sequence":"additional","affiliation":[]},{"given":"R.","family":"Campbell Tait","sequence":"additional","affiliation":[]},{"given":"Jonathon T.","family":"Wilde","sequence":"additional","affiliation":[]},{"given":"K.","family":"John Pasi","sequence":"additional","affiliation":[]},{"given":"Frank G. H.","family":"Hill","sequence":"additional","affiliation":[]},{"name":"on behalf of UK Haemophilia Centre Doctors\u2019 Organization","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2005,3,8]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_16_2_1","DOI":"10.1055\/s-0037-1616205"},{"key":"e_1_2_16_3_1","first-page":"247","article-title":"Mild bleeding disorders: review of 120 patients","volume":"6","author":"Bolton\u2010Maggs P.","year":"1984","journal-title":"Clinical and Laboratory Haematology"},{"doi-asserted-by":"publisher","key":"e_1_2_16_4_1","DOI":"10.1046\/j.1538-7836.2003.00007.x"},{"doi-asserted-by":"publisher","key":"e_1_2_16_5_1","DOI":"10.1182\/blood-2004-01-0376"},{"doi-asserted-by":"publisher","key":"e_1_2_16_6_1","DOI":"10.1182\/blood-2003-05-1505"},{"doi-asserted-by":"publisher","key":"e_1_2_16_7_1","DOI":"10.1046\/j.1365-2141.2001.03132.x"},{"doi-asserted-by":"publisher","key":"e_1_2_16_8_1","DOI":"10.1055\/s-0037-1614330"},{"doi-asserted-by":"publisher","key":"e_1_2_16_9_1","DOI":"10.1136\/jcp.36.8.915"},{"doi-asserted-by":"publisher","key":"e_1_2_16_10_1","DOI":"10.1016\/S0049-3848(98)00078-4"},{"key":"e_1_2_16_11_1","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterisation of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan M.","year":"1996","journal-title":"Blood"},{"doi-asserted-by":"publisher","key":"e_1_2_16_12_1","DOI":"10.1182\/blood.V69.6.1691.1691"},{"doi-asserted-by":"publisher","key":"e_1_2_16_13_1","DOI":"10.1046\/j.1365-2516.1999.0050s2072.x"},{"key":"e_1_2_16_14_1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Prevalence of von Willebrand's disease among US adults","volume":"69","author":"Miller C.H.","year":"1987","journal-title":"Blood"},{"doi-asserted-by":"publisher","key":"e_1_2_16_15_1","DOI":"10.1182\/blood-2002-12-3693"},{"doi-asserted-by":"publisher","key":"e_1_2_16_16_1","DOI":"10.1182\/blood.V69.2.454.454"},{"doi-asserted-by":"publisher","key":"e_1_2_16_17_1","DOI":"10.1046\/j.1538-7836.2003.00260.x"},{"key":"e_1_2_16_18_1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler J.E.","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"doi-asserted-by":"publisher","key":"e_1_2_16_19_1","DOI":"10.1182\/blood-2002-09-2892"},{"doi-asserted-by":"publisher","key":"e_1_2_16_20_1","DOI":"10.1046\/j.1365-2516.1999.0050s2071.x"},{"key":"e_1_2_16_21_1","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai H.M.","year":"1996","journal-title":"Blood"},{"doi-asserted-by":"publisher","key":"e_1_2_16_22_1","DOI":"10.1016\/S0022-3476(05)80384-1"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05375.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05375.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:21:52Z","timestamp":1697379712000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05375.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05375.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05375.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"type":"print","value":"0007-1048"},{"type":"electronic","value":"1365-2141"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"2005-03-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}